Parkinson’s Disease: A Neurodegenerative Disease

Journal Title: Journal of Clinical Medical Research - Year 2022, Vol 3, Issue 2

Abstract

Parkinson’s disease is characterized by tremor, stiffness, rigid muscles, bradykinesia, slowness of movement, instability leading to falls, memory and talking difficulties, fatigue, writing modifications (micrography) and dementia. In addition, depression, urinary (bladder) problems, constipation, decreased ability to smell and sleep disruption are among the symptoms associated to the PD. As Parkinson’s cannot be eradicate, treatments are oriented toward a slow decline and deterioration and therefore, only palliative care predominates. Mutations of 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1 and ATP13A2), are the cause of familial Parkinsonism. They are playing a role in the metabolism of α-synucleine, in mitochondrial control, oxidative stress, lysosomal functions, transport and recycling of proteins and immunologic activities. Five stages with increased gravity have been identified. From stage 1 to 3, symptoms may be treated with pharmacological drugs. At stages 4 and 5, the patient needs assistive help and an ambulatory walker device. L-dopa is transformed in dopamine in the brain. Treatments for speech disorders increase the disability of these symptoms. Dopamine agonists, MAO-B and COMT inhibitors contribute to help break down dopamine, an anticholinergic drug aiming to reduce tremors and muscle rigidity. Death is occurring within 7 to 15 years.

Authors and Affiliations

Michel Goldberg1*

Keywords

Related Articles

Microfracture and Hydrogel Scaffolds for the Treatment of Osteochondral Injuries of the Knee: Clinical Results at 4 Years Follow-Up

The aim of this study is to evaluate the outcomes of microfracture technique and novel hydrogel scaffold for the treatment of osteochondral injuries of the knee. Forty-one patients affected by grade III and IV osteocho...

The Use of Intra-Operative Brilliance Amplifier by Novice Surgeons to Improve Bone Tunnels Placement in Anterior Cruciate Ligament Reconstruction during Residency Curriculum: Useful or Not?

Objective: Our objective was to evaluate the contribution of the use of intra-operative fluoroscopy on tunnels positioning during the Anterior Cruciate Ligament (ACL) reconstruction. Methods: Between January 2020 and...

The Influence of Gene Mutations on Bone and Teeth: Osteogenesis and Dentinogenesis Imperfecta

Osteogenesis Imperfecta (OI) are inherited disorders generating skeletal fragility. It is caused by mutations in one of the two genes encoding type I collagen (COL-1A1, COL1A2). Four subtypes of OI has been identified:...

Effect of Early Administration of Oropharyngeal Colostrum in Reducing Late Onset Neonatal Sepsis

Background: Early administration of colostrum by oropharyngeal route plays a tremendous role in preventing mortality and morbidity in preterm infants. The objective of this study was to determine if oropharyngeal adminis...

Cortical Mandibular Bone Blocks Grafts and Piezoelectric Surgery in Complex Anterior Maxillary Alveolar Defects: A Case Report and Literature Review

The aim of this study is to assess the indication and efficacy of alveolar ridge reconstructions for complex horizontal and vertical augmentation procedures in the maxillary anterior area with Cortical Mandibular Bone Bl...

Download PDF file
  • EP ID EP704386
  • DOI http://dx.doi.org/10.46889/JCMR.2022.3203
  • Views 83
  • Downloads 0

How To Cite

Michel Goldberg1* (2022). Parkinson’s Disease: A Neurodegenerative Disease. Journal of Clinical Medical Research, 3(2), -. https://europub.co.uk/articles/-A-704386